PEPG
PepGen Inc. - Common Stock (PEPG)
$54
About PepGen Inc. - Common Stock (PEPG)
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
Details
Daily high
$1.68
Daily low
$1.52
Price at open
$1.68
52 Week High
$19.30
52 Week Low
$0.88
Market cap
54.9M
Dividend yield
0.00%
Volume
91,275
Avg. volume
243,221
P/E ratio
-.59
PepGen Inc. - Common Stock News
Details
Daily high
$1.68
Daily low
$1.52
Price at open
$1.68
52 Week High
$19.30
52 Week Low
$0.88
Market cap
54.9M
Dividend yield
0.00%
Volume
91,275
Avg. volume
243,221
P/E ratio
-.59